
Pharma giant AstraZeneca eyes NYSE listing overhaul, keeps London base
AstraZeneca announced plans to change how it lists shares in the United States by moving from American depositary receipts (ADRs) on Nasdaq to a di...

The Week’s 10 Biggest Funding Rounds: Nirvana Insurance, Nucleus RadioPharma Lead Week With No Big Rounds
There is only one way to describe this week — incredibly slow. For the first time in a while, there wasn’t a round that hit nine figures. After a s...